"Pharmaceuticals firm Oxford Biomedica remained in demand amid continuing speculation of a bid from its major licensing partner, Sanofi-Aventis. The shares spiked 3¼ to 27p in very brisk trading, with 57m shares changing hands."
http://www.telegraph.co.uk/money/main.jhtml?xml=/money/2008/02/13/cxmktrep113.xml
Wednesday, February 13, 2008
OXB
